N/A
Completed N=197
Utilizing Augmented Reality as an Adjunct for Smoking Cessation
Source: ClinicalTrials.gov NCT04101422 ↗Enrolled (actual)
197
Serious AEs
0.0%
Results posted
May 2023
Primary outcomePrimary: Urge to Smoke - Pilot Testing — 4.58; 1.42 score on a scale
Summary
The purpose of the study is to develop an preliminary test a tobacco smoking-related augmented reality (AR) paradigm for eventual development as an adjunctive tobacco cessation intervention.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Urge to Smoke - Pilot Testing |
4.58; 1.42 | — |
| PRIMARY Urge to Smoke - AR Stimuli Session 1 |
7.50; 3.33 | — |
| PRIMARY Urge to Smoke - AR Stimuli Session 2 |
5.3; 6.4 | — |
| PRIMARY Urge to Smoke - Testing AR Application |
7.28 | — |
| SECONDARY Reality/Co-Existence - Pilot Testing |
6.49; 6.93; 6.38 | — |
| SECONDARY Reality/Co-Existence - AR Stimuli Session 1 |
7.83; 7.83; 7.17 | — |
| SECONDARY Reality/Co-Existence - AR Stimuli Session 2 |
7.91; 7.96; 8.04 | — |
Eligibility Criteria
Inclusion Criteria
- Currently smoking ≥ 3 cigarettes per day for the past year
- Breath carbon monoxide (CO) level ≥ 5 ppm
- Motivated to quit smoking
- Aim 1 & 2 Only: Valid home address in the Tampa Bay area
- Functioning telephone number
- Can speak, read, and write in English
- Aim 3: Must have a smartphone that participant is willing to use during the study
- Aim 3: Motivated to quit smoking within the next month
Exclusion Criteria
- Regular use (e.g., no more than 1/3 of month) of other tobacco products (cigars)
- Household member already enrolled in the study
Data sourced from ClinicalTrials.gov (NCT04101422). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.